ResMed [RMD] vs Hologic [HOLX] Detailed Stock Comparison

ResMed Inc.

NYSE
Loading...

Hologic Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: ResMed Inc. wins in 13 metrics, Hologic Inc. wins in 7 metrics, with 0 ties. ResMed Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric ResMed Inc. Hologic Inc. Better
P/E Ratio (TTM) 21.69 31.54 ResMed Inc.
Price-to-Book Ratio 5.06 3.23 Hologic Inc.
Debt-to-Equity Ratio 13.41 48.05 ResMed Inc.
PEG Ratio 1.50 -3.92 ResMed Inc.
EV/EBITDA 15.51 12.68 Hologic Inc.
Profit Margin (TTM) 27.53% 13.18% ResMed Inc.
Operating Margin (TTM) 35.16% 22.99% ResMed Inc.
EBITDA Margin (TTM) 35.16% 22.99% ResMed Inc.
Return on Equity 25.68% 10.86% ResMed Inc.
Return on Assets (TTM) 14.75% 7.43% ResMed Inc.
Free Cash Flow (TTM) $1.65B $904.70M ResMed Inc.
Dividend Yield 0.92% N/A N/A
1-Year Return -21.88% 31.39% Hologic Inc.
Price-to-Sales Ratio (TTM) 5.92 4.11 Hologic Inc.
Enterprise Value $31.41B $17.12B ResMed Inc.
EV/Revenue Ratio 5.82 4.15 Hologic Inc.
Gross Profit Margin (TTM) 61.76% 55.96% ResMed Inc.
Revenue per Share (TTM) $37 $18 ResMed Inc.
Earnings per Share (Diluted) $10.12 $2.41 ResMed Inc.
Beta (Stock Volatility) 0.93 0.70 Hologic Inc.
Short % of Float 9.40% 3.66% Hologic Inc.

ResMed Inc. vs Hologic Inc. Stock Performance Analysis

Loading Price Chart...

RMD
HOLX

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
ResMed Inc.-1.05%-0.21%-4.53%-16.42%-23.84%-21.27%
Hologic Inc.0.00%0.56%0.56%1.40%12.23%1.94%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
ResMed Inc.-21.88%-11.08%-17.97%233.76%527.92%775.81%
Hologic Inc.31.39%-9.66%-0.85%110.15%246.29%206.74%

Performance & Financial Health Analysis: ResMed Inc. vs Hologic Inc.

MetricRMDHOLX
Market Information
Market Cap i$32.03B$16.97B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i955,84212,273,085
90 Day Avg. Volume i1,020,5546,282,625
Last Close$192.74$76.01
52 Week Range$180.27 - $293.81$51.90 - $76.07
% from 52W High-34.40%-0.08%
All-Time High$301.34 (Sep 06, 2021)$87.88 (May 01, 2023)
% from All-Time High-36.04%-13.51%
Growth Metrics
Quarterly Revenue Growth0.11%0.03%
Quarterly Earnings Growth0.14%-0.11%
Financial Health
Profit Margin (TTM) i0.28%0.13%
Operating Margin (TTM) i0.35%0.23%
Return on Equity (TTM) i0.26%0.11%
Debt to Equity (MRQ) i13.4148.05
Cash & Liquidity
Book Value per Share (MRQ)$43.39$23.51
Cash per Share (MRQ)$9.73$10.60
Operating Cash Flow (TTM) i$1.91B$1.10B
Levered Free Cash Flow (TTM) i$1.42B$848.61M
Dividends
Last 12-Month Dividend Yield i0.92%N/A
Last 12-Month Dividend i$2.33N/A

Valuation & Enterprise Metrics Analysis: ResMed Inc. vs Hologic Inc.

MetricRMD (Apr 26, 2026)HOLX (Apr 19, 2026)
Price Ratios
P/E Ratio (TTM) i21.6931.54
Forward P/E i18.0215.64
PEG Ratio i1.50-3.92
Price to Sales (TTM) i5.924.11
Price to Book (MRQ) i5.063.23
Market Capitalization
Market Capitalization i$32.03B$16.97B
Enterprise Value i$31.41B$17.12B
Enterprise Value Metrics
Enterprise to Revenue i5.824.15
Enterprise to EBITDA i15.5112.68
Risk & Other Metrics
Beta i0.930.70
Book Value per Share (MRQ) i$43.39$23.51

Financial Statements Comparison: ResMed Inc. vs Hologic Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricRMD (2025)HOLX (2025)
Revenue/Sales i5.15B4.10B
Cost of Goods Sold i2.09B1.98B
COGS % of Revenue i40.6%48.4%
Gross Profit i3.05B2.12B
Gross Margin i59.4%51.6%
Research & Development i331.28M248.20M
Operating Income (EBIT) i1.69B785.40M
Operating Margin i32.8%19.2%
EBITDA i1.93B1.17B
EBITDA Margin i37.4%28.5%
Pre-Tax Income i1.68B681.20M
Pre-Tax Income % of Revenue i32.6%16.6%
Income Tax i276.84M115.50M
Income Tax % of Revenue i5.4%2.8%
Net Income (Profit) i1.40B565.70M
Profit Margin i27.2%13.8%

Balance Sheet & Liquidity Metrics

MetricRMD (2025)HOLX (2025)
Cash & Equivalents i1.21B1.96B
Total Current Assets i3.51B3.67B
Total Current Assets % of Revenue i68.1%89.5%
Total Current Liabilities i1.02B977.20M
Total Current Liabilities % of Revenue i19.8%23.8%
Long-Term Debt i811.41M2.59B
Long-Term Debt % of Revenue i15.8%63.2%
Total Shareholders Equity i5.97B5.05B
Retained Earnings i6.08B3.41B
Retained Earnings % of Revenue i118.2%83.2%
Property, Plant & Equipment i288.62M1.07B

Cash Flow Statement Comparison

MetricRMD (2025)HOLX (2025)
Operating Cash Flow i1.57B831.50M
Operating Cash Flow % of Revenue i30.5%20.3%
Capital Expenditures i-89.87M-78.20M
Free Cash Flow i1.65B904.70M
FCF Margin i32.1%22.1%
Debt Repayment i-40.00M-1.20B
Common Stock Repurchase i-300.03M-752.90M

Short Interest & Institutional Ownership Analysis

MetricRMDHOLX
Shares Short i11.89M7.10M
Short Ratio i11.242.78
Short % of Float i9.40%3.66%
Shares Outstanding i145.66M223.07M
Float Shares i144.79M221.21M
% Held by Insiders i0.50%0.84%
% Held by Institutions i68.82%96.52%
% Held by Public i30.68%2.64%

Dividend Analysis & Yield Comparison: ResMed Inc. vs Hologic Inc.

MetricRMDHOLX
Last 12-Month Dividend i$2.33N/A
Last 12-Month Dividend Yield i0.92%N/A
3-Year Avg Annual Dividend i$2.09N/A
3-Year Avg Dividend Yield i0.24%N/A
3-Year Total Dividends i$6.28N/A
Ex-Dividend DateFeb 12, 2026N/A